Related Experiment Video
Updated: Jul 17, 2026
08:01
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Seminal hemostatic factors: then and now
Bashir A Lwaleed1, Anuj Goyal, George H Delves
1Department of Urology, Southampton University Hospitals, Southampton, United Kingdom. bashir@soton.ac.uk
Seminars in Thrombosis and Hemostasis
|January 27, 2007
Summary
Human semen proteins involved in blood clotting regulate semen liquefaction. This process may offer insights into male fertility diagnostics and reproductive therapies.
Area of Science:
- Reproductive Biology
- Biochemistry
- Hemostasis
Background:
- Human semen undergoes coagulation and liquefaction post-ejaculation.
- The precise mechanisms governing these processes remain incompletely understood.
- Seminal proteins share similarities with those involved in blood coagulation and fibrinolysis.
Purpose of the Study:
- To review and synthesize current knowledge on seminal proteins with hemostatic functions.
- To explore potential analogies between seminal and blood coagulation pathways.
- To correlate seminal hemostatic factors with male fertility indices.
Main Methods:
- Literature review of existing research on seminal coagulation and liquefaction.
- Analysis of data on hemostatically functional seminal proteins.
- Examination of findings related to male fertility and reproductive therapies.
Main Results:
- Several hemostatic factors are present in human semen.
- These factors may influence male fertility.
- Potential alternative functions include anti-inflammatory action and sperm capacitation.
- The high molecular weight seminal vesicle system may interact with hemostatic pathways.
Conclusions:
- Seminal coagulation and liquefaction share functional similarities with blood hemostasis.
- Further research is needed to fully elucidate these mechanisms.
- Understanding these pathways could advance male infertility diagnostics and assisted reproduction.
Related Concept Videos
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...